🇺🇸 FDA
Patent

US 9267151

STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness

granted A61PA61P25/00A61P25/18

Quick answer

US patent 9267151 (STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness) held by UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA
Grant date
Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P25/00, A61P25/18